85820-9
LaboratoryClot firmness reduction [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude + heparinase
Definition
In this assay, the reduction of clot firmness (i.e., clot lysis), is measured 30 minutes after maximum clot amplitude is reached. Heparinase is added prior to starting the assay in order to eliminate interference by any heparin that is in the patient's sample.
LOINC 6-Axis Classification
Component
Clot firmness reduction^30M after maximum clot amplitude after addition of heparinase
Property
LenFr
Time Aspect
Pt
System
Bld
Scale Type
Qn
Method Type
Thromboelastography
Details
Class
COAG
Order/Observation
Both
Short Name
CF reduc 30M p MA p hep LenFr Bld TEG
Display Name
Clot firmness reduction 30 Min p max clot amplitude + heparinase TEG (Bld) [Length fraction]
Related Names
Frequently Asked Questions
What is LOINC code 85820-9?
LOINC code 85820-9 identifies "Clot firmness reduction [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude + heparinase". In this assay, the reduction of clot firmness (i.e., clot lysis), is measured 30 minutes after maximum clot amplitude is reached. Heparinase is added prior to starting the assay in order to eliminate interference by any heparin that is in the patient's sample.
What does 85820-9 measure?
This code measures Clot firmness reduction^30M after maximum clot amplitude after addition of heparinase in Bld. It belongs to the COAG class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.